AmSECT Membership Renewal (Video)

Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass

Therapy with recombinant activated factor VII (rFVIIa) may be an effective treatment strategy for patients with refractory bleeding.

International Perfusion Journal Vol. 2 No. 6

Table of Contents: IntroductionReview of Empty Venous Line Technique with Gerard Meyers  Empty Venous Line Technique, a Supporting  View John Brooks, Chief […]